ProQR (PRQR) backs new director, capital increase and share authorizations

Rhea-AI Filing Summary

ProQR Therapeutics N.V. reports the results of its 2026 annual general meeting held on June 2, 2026. Shareholders adopted the 2025 annual accounts and appropriation of net result with 99.7% of votes cast in favor.

They granted discharge from liability to Board members for their 2025 duties with 69.5% support and approved the appointment of Dr. Lykke Hinsch Gylvin as a non-executive Board member with 99.7% support. KPMG Accountants N.V. was appointed external auditor for the 2027 financial year with 99.8% approval.

Shareholders also approved amendments to the Articles of Association to increase authorized capital with 65.4% support, authorized the Board to issue ordinary shares with 64.3% support, and to repurchase ordinary shares with 66.7% support. Following the meeting, the Board confirmed updated Audit, Compensation/Nominating/Corporate Governance, and Research and Development committee compositions.

Key Figures

Adoption of 2025 annual accounts support: 99.7% of votes cast Board discharge for 2025 support: 69.5% of votes cast New non-executive director support: 99.7% of votes cast +5 more

8 metrics

Adoption of 2025 annual accounts support 99.7% of votes cast Agenda Item 3 approval at 2026 AGM

Board discharge for 2025 support 69.5% of votes cast Agenda Item 4 approval

New non-executive director support 99.7% of votes cast Appointment of Dr. Lykke Hinsch Gylvin, Agenda Item 5(a)

2027 auditor appointment support 99.8% of votes cast Appointment of KPMG Accountants N.V., Agenda Item 6

Authorized capital increase support 65.4% of votes cast Amendment of Articles of Association, Agenda Item 7

Share issuance authorization support 64.3% of votes cast Board authorization to issue ordinary shares, Agenda Item 8

Share repurchase authorization support 66.7% of votes cast Board authorization to acquire ordinary shares, Agenda Item 9

AGM date June 2, 2026 Date of 2026 annual general meeting

Key Terms

Articles of Association, authorized capital, non-executive member of the Board, external auditor, +2 more

6 terms

Articles of Association regulatory

"Amendment of Articles of Association regarding increase of authorized capital."

A company's articles of association are its written rulebook that sets how the business is run, how decisions are made, and what rights owners and directors have—covering voting, meetings, appointment and removal of directors, share classes and dividend policies. For investors, these rules matter because they determine how easily control can change, what protections minority owners have, and how corporate actions (like issuing new shares or changing leadership) are approved, much like a home’s bylaws shaping what residents can and cannot do.

authorized capital financial

"Amendment of the Articles of Association regarding the increase of the authorized capital."

Authorized capital is the maximum value or number of shares a company is legally allowed to issue as set in its founding documents. For investors, it signals how much the company can expand ownership or raise money without changing those documents, which affects the risk of ownership being diluted and the company’s flexibility to fund growth—think of it like the number of seats allowed on a bus before you must buy a new one.

non-executive member of the Board financial

"Appointment of Dr. Lykke Hinsch Gylvin as non-executive member of the Board."

external auditor financial

"Appointment of KPMG Accountants N.V. as the Company’s external auditor for the financial year 2027."

An external auditor is an independent, third-party professional who reviews a company’s financial records and reports to confirm they are accurate and follow the rules. Like a home inspector checking a house before you buy, an external auditor gives investors assurance that the numbers reflect reality, which affects trust, the perceived risk of the company, and therefore investment decisions and value.

Audit Committee financial

"Audit Committee: Bart Filius (Chair), Begona Carreno-Gomez and Theresa Heggie."

A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.

Compensation, Nominating and Corporate Governance Committee financial

"Compensation, Nominating and Corporate Governance Committee: Theresa Heggie (Chair), James Shannon and Bart Filius."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the month of June 2026

Commission File Number: 001-36622

PROQR THERAPEUTICS N.V.

Zernikedreef 9

2333 CK Leiden

The Netherlands

Tel: +31 88 166 7000

(Address, Including Zip Code, and Telephone Number,
Including Area Code, of Registrant’s Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x  Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Annual General Meeting Results

On June 2, 2026, ProQR Therapeutics N.V. (“ProQR” or the “Company”) held its 2026 annual general meeting of shareholders (the “Annual Meeting”) at the offices of Allen Overy Shearman Sterling LLP, Apollolaan 15, 1077 AB in Amsterdam, the Netherlands. The final results of each of the agenda items submitted to a vote of the shareholders are as follows:

Agenda Item 3: Adoption of the annual accounts, including the appropriation of net result, for the financial year 2025.

ProQR shareholders approved the adoption of the annual accounts, including the appropriation of net result, for the financial year 2025, with 99.7% of the votes cast in favor of Agenda Item 3.

Agenda Item 4: Release from liability of each member of the Company’s Board of Directors (the “Board”) with respect to the performance of their duties during the financial year 2025.

ProQR shareholders approved the release from liability of each member of the Board with respect to the performance of their duties during the financial year 2025, with 69.5% of the votes cast in favor of Agenda Item 4.

Agenda Item 5(a): Appointment of Dr. Lykke Hinsch Gylvin as non-executive member of the Board.

ProQR shareholders approved the appointment of Dr. Lykke Hinsch Gylvin as non-executive member of the Board, with 99.7% of the votes cast in favor of Agenda Item 5(a).

Agenda Item 6: Appointment of KPMG Accountants N.V. as the Company’s external auditor for the financial year 2027.

ProQR shareholders approved the appointment of KPMG Accountants N.V. as the Company’s external auditor for the financial year 2027, with 99.8% of the votes cast in favor of Agenda Item 6.

Agenda Item 7: Amendment of Articles of Association regarding increase of authorized capital.

ProQR shareholders approved the amendment of the Articles of Association regarding the increase of the authorized capital, with 65.4% of the votes cast in favor of Agenda Item 7.

Agenda Item 8: Authorization of the Board to issue ordinary shares.

ProQR shareholders approved the authorization of the Board to issue ordinary shares, with 64.3% of the votes cast in favor of Agenda Item 8.

Agenda Item 9: Authorization of the Board to acquire ordinary shares in the capital of the Company.

ProQR shareholders approved the authorization of the Board to acquire ordinary shares in the capital of the Company, with 66.7% of the votes cast in favor of Agenda Item 9.

Board Committee Composition

Effective June 2, 2026, following the Annual Meeting, the Board determined the composition of its committees as follows:

Audit Committee: Bart Filius (Chair), Begona Carreno-Gomez and Theresa Heggie.

Compensation, Nominating and Corporate Governance Committee: Theresa Heggie (Chair), James Shannon and Bart Filius.

Research and Development Committee: James Shannon (Chair), Martin Maier and Lykke Hinsch Gylvin.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	PROQR THERAPEUTICS N.V.
Date: June 2, 2026	By:	/s/ Daniel de Boer
		Daniel de Boer
		Chief Executive Officer

FAQ

What key resolutions did ProQR (PRQR) shareholders approve at the 2026 AGM?

Shareholders approved the 2025 annual accounts, Board discharge for 2025, a new non-executive director, KPMG as 2027 auditor, amendments to increase authorized capital, and authorizations to issue and repurchase ordinary shares, each with majority support.

How strong was shareholder support for ProQR’s 2025 annual accounts and results?

Support was very high: 99.7% of votes cast favored adopting the 2025 annual accounts and appropriation of net result. This indicates broad shareholder backing for the company’s reported financials and profit allocation for the 2025 financial year.

What capital-related authorizations were granted to ProQR (PRQR) at the 2026 AGM?

Shareholders approved amending the Articles of Association to increase authorized capital with 65.4% support and authorized the Board to issue ordinary shares with 64.3% support and to acquire ordinary shares with 66.7% support, expanding future capital management flexibility.

Who was appointed as ProQR’s new non-executive Board member in 2026?

Dr. Lykke Hinsch Gylvin was appointed as a non-executive member of the Board, receiving 99.7% of votes cast in favor. She also joined the Research and Development Committee alongside James Shannon and Martin Maier after the meeting.

Which audit firm will serve as ProQR’s external auditor for the 2027 financial year?

KPMG Accountants N.V. was appointed as ProQR’s external auditor for the 2027 financial year, with 99.8% of votes cast supporting the proposal. This confirms KPMG’s role in auditing the company’s 2027 financial statements.

How did ProQR structure its Board committees after the June 2, 2026 AGM?

After the meeting, the Audit Committee comprised Bart Filius (Chair), Begona Carreno-Gomez and Theresa Heggie. The Compensation, Nominating and Corporate Governance Committee included Theresa Heggie (Chair), James Shannon and Bart Filius. The Research and Development Committee was led by James Shannon with Martin Maier and Lykke Hinsch Gylvin.